Cognition is dependent upon the proper formation of neural circuits and the adaptations of those circuits in response to experience. The cellular and molecular mechanisms underlying declarative learning and memory constitute a predominant area in basic neurobiological research and are of considerable clinical relevance. Dysregulation of the biochemical mechanisms underlying cognition likely contributes to neurodevelopmental and neurodegenerative disorders including autism, Alzheimer's, mental retardation, schizophrenia, and attention deficit and hyperactivity disorder. We have focused on synaptic signal transduction mechanisms involving the neuronal protein kinase Cdk5, with the goal of determining its role in learning and memory. We developed an innovative transgenic approach that allowed the induction of knockout of the neuronal protein throughout the brain of adult mice. This led to the discovery that the neuronal protein kinase Cdk5 governs synaptic plasticity, learning, and memory. We found that this was due to changes in the levels and surface expression of the NR2B subunit of the NMDA receptor. Here we propose to characterize the interactions between Cdk5 and NR2B, evaluate the role of Cdk5-NR2B interactions in synaptic plasticity, and assess the role of Cdk5-NR2B interaction in learning, and memory. The proposed studies are based on our preliminary findings that Cdk5 phosphorylates NR2B at a novel site and this phosphorylation controls the translocation of the receptor to the synaptic cell surface. We will characterize the regulation of this important site with regard to phosphorylation/dephosphorylation and define its physiological function. We hypothesize that the phosphorylation state of NR2B is dynamically regulated during learning and essential for consolidation of memory in the hippocampus. Furthermore, we show that are developing small drug-like interfering peptides based that disrupt Cdk5-NR2B interactions in vitro and in vivo. We will use this selective targeting approach to manipulate Cdk5-NR2B interactions and bidirectionally control the phosphorylation state and surface levels of NR2B. This will allow us to modulate synaptic plasticity, learning and memory in the hippocampus. Thus by combining advanced transgenic, biochemical, neurophysiological and behavioral approaches, we will define an important new mechanism that mediates cognition and demonstrate it as a target for the possible development of innovate disruption strategies to treat cognitive disorders.

Public Health Relevance

Unlike many other diseases, the high levels of morbidity and health care burden of neurodevelopmental and neurodegenerative disorders has not been reduced by modern advances in medicine. Many neuropsychiatric and neurological illnesses such as autism, Alzheimer's, mental retardation, schizophrenia, and attention deficit and hyperactivity disorder may involve the dysregulation of the cellular and molecular mechanisms that mediate cognition. The goal of this research is to identify and understand novel biochemical mechanisms that mediate cognition and develop reagents that will improve learning and memory, and lead to innovative disruption strategies for mental illness and neurological disorders.

National Institute of Health (NIH)
National Institute of Mental Health (NIMH)
Research Project (R01)
Project #
Application #
Study Section
Neurobiology of Learning and Memory Study Section (LAM)
Program Officer
Asanuma, Chiiko
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
Schools of Medicine
United States
Zip Code
Meyer, Douglas A; Torres-Altoro, Melissa I; Tan, Zhenjun et al. (2014) Ischemic stroke injury is mediated by aberrant Cdk5. J Neurosci 34:8259-67
Mettlach, Gabriel; Polo-Parada, Luis; Peca, Lauren et al. (2014) Enhancement of neuromuscular dynamics and strength behavior using extremely low magnitude mechanical signals in mice. J Biomech 47:162-7
Plattner, Florian; Hernández, Adan; Kistler, Tara M et al. (2014) Memory enhancement by targeting Cdk5 regulation of NR2B. Neuron 81:1070-83
Bankston, Andrew N; Li, Wenqi; Zhang, Hui et al. (2013) p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair. J Biol Chem 288:18047-57
Yang, Yan; Wang, Haibo; Zhang, Jie et al. (2013) Cyclin dependent kinase 5 is required for the normal development of oligodendrocytes and myelin formation. Dev Biol 378:94-106
Petrik, David; Yun, Sanghee; Latchney, Sarah E et al. (2013) Early postnatal in vivo gliogenesis from nestin-lineage progenitors requires cdk5. PLoS One 8:e72819
Pozo, Karine; Castro-Rivera, Emely; Tan, Chunfeng et al. (2013) The role of Cdk5 in neuroendocrine thyroid cancer. Cancer Cell 24:499-511
Kuroiwa, Mahomi; Snyder, Gretchen L; Shuto, Takahide et al. (2012) Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex. Psychopharmacology (Berl) 219:1065-79
Torres-Altoro, Melissa I; Mathur, Brian N; Drerup, Justin M et al. (2011) Organophosphates dysregulate dopamine signaling, glutamatergic neurotransmission, and induce neuronal injury markers in striatum. J Neurochem 119:303-13
Wang, Allan; Bibb, James A (2011) Is CREB the angry bird that releases memory in Alzheimer's? Neuropsychopharmacology 36:2153-4

Showing the most recent 10 out of 13 publications